80 related articles for article (PubMed ID: 9241752)
1. Regulation, location and activity of plasminogen activator inhibitor 2 (PAI-2) in peripheral blood monocytes, macrophages and foam cells.
Ritchie H; Jamieson A; Booth NA
Thromb Haemost; 1997 Jun; 77(6):1168-73. PubMed ID: 9241752
[TBL] [Abstract][Full Text] [Related]
2. Peripheral blood monocyte synthesis of plasminogen activator inhibitor 2 in response to native and modified LDL.
Ritchie H; Jamieson A; Booth NA
Thromb Haemost; 1995 Dec; 74(6):1521-7. PubMed ID: 8772231
[TBL] [Abstract][Full Text] [Related]
3. Monocyte plasminogen activator inhibitor 2 (PAI-2) inhibits u-PA-mediated fibrin clot lysis and is cross-linked to fibrin.
Ritchie H; Robbie LA; Kinghorn S; Exley R; Booth NA
Thromb Haemost; 1999 Jan; 81(1):96-103. PubMed ID: 10348718
[TBL] [Abstract][Full Text] [Related]
4. The distribution of the secreted and intracellular forms of plasminogen activator inhibitor 2 (PAI-2) in human peripheral blood monocytes is modulated by serum.
Ritchie H; Booth NA
Thromb Haemost; 1998 Apr; 79(4):813-7. PubMed ID: 9569198
[TBL] [Abstract][Full Text] [Related]
5. Thrombin inhibits apoptosis of monocytes and plasminogen activator inhibitor 2 (PAI-2) is not responsible for this inhibition.
Ritchie H; Fragoyannis A
Exp Cell Res; 2000 Oct; 260(1):20-9. PubMed ID: 11010807
[TBL] [Abstract][Full Text] [Related]
6. Plasminogen activator production by bovine milk macrophages and blood monocytes.
Politis I; Zhao X; McBride BW; Burton JH; Turner JD
Am J Vet Res; 1991 Aug; 52(8):1208-13. PubMed ID: 1928901
[TBL] [Abstract][Full Text] [Related]
7. Secretion of plasminogen activator inhibitor 2 by human peripheral blood monocytes occurs via an endoplasmic reticulum-golgi-independent pathway.
Ritchie H; Booth NA
Exp Cell Res; 1998 Aug; 242(2):439-50. PubMed ID: 9683531
[TBL] [Abstract][Full Text] [Related]
8. Increased thrombogenic potential of human monocyte-derived macrophages spontaneously transformed into foam cells.
Colli S; Lalli M; Risè P; Mussoni L; Eligini S; Galli C; Tremoli E
Thromb Haemost; 1999 Apr; 81(4):576-81. PubMed ID: 10235442
[TBL] [Abstract][Full Text] [Related]
9. Plasminogen activator-specific inhibitors in mouse macrophages: in vivo and in vitro modulation of their synthesis and secretion.
Wohlwend A; Belin D; Vassalli JD
J Immunol; 1987 Aug; 139(4):1278-84. PubMed ID: 3112228
[TBL] [Abstract][Full Text] [Related]
10. Thrombin modulates synthesis of plasminogen activator inhibitor type 2 by human peripheral blood monocytes.
Ritchie H; Jamieson A; Booth NA
Blood; 1995 Nov; 86(9):3428-35. PubMed ID: 7579447
[TBL] [Abstract][Full Text] [Related]
11. Modulation of tissue plasminogen activator and plasminogen activator inhibitor-1 by transforming growth factor-beta in human retinal glial cells.
Schacke W; Beck KF; Pfeilschifter J; Koch F; Hattenbach LO
Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2799-805. PubMed ID: 12147618
[TBL] [Abstract][Full Text] [Related]
12. Modulation of PAI-1 and proMMP-9 syntheses by soluble TNFalpha and its receptors during differentiation of the human monocytic HL-60 cell line.
Peiretti F; Bernot D; Lopez S; Bonardo B; Deprez-Beauclair P; Juhan-Vague I; Nalbone G
J Cell Physiol; 2003 Aug; 196(2):346-53. PubMed ID: 12811828
[TBL] [Abstract][Full Text] [Related]
13. Hydrocortisone regulates the dynamics of plasminogen activator and plasminogen activator inhibitor expression in cultured murine keratinocytes.
Bator JM; Cohen RL; Chambers DA
Exp Cell Res; 1998 Jul; 242(1):110-9. PubMed ID: 9665808
[TBL] [Abstract][Full Text] [Related]
14. Progestin inhibits and thrombin stimulates the plasminogen activator/inhibitor system in term decidual stromal cells: implications for parturition.
Norwitz ER; Snegovskikh V; Schatz F; Foyouzi N; Rahman M; Buchwalder L; Lee HJ; Funai EF; Buhimschi CS; Buhimschi IA; Lockwood CJ
Am J Obstet Gynecol; 2007 Apr; 196(4):382.e1-8. PubMed ID: 17403427
[TBL] [Abstract][Full Text] [Related]
15. The molecular basis for the aberrant production of plasminogen activator inhibitor type 2 in THP-1 monocytes.
Katsikis J; Yu H; Maurer F; Medcalf R
Thromb Haemost; 2000 Sep; 84(3):468-73. PubMed ID: 11019973
[TBL] [Abstract][Full Text] [Related]
16. Modulating effect of serum on the stimulation of plasminogen activator inhibitor 2 production in human gingival fibroblasts by lipopolysaccharide and interleukin-1beta.
Xiao Y; Bartold PM
J Int Acad Periodontol; 2004 Jul; 6(3):81-8. PubMed ID: 15368874
[TBL] [Abstract][Full Text] [Related]
17. Macrophages and platelets are the major source of protease nexin-1 in human atherosclerotic plaque.
Mansilla S; Boulaftali Y; Venisse L; Arocas V; Meilhac O; Michel JB; Jandrot-Perrus M; Bouton MC
Arterioscler Thromb Vasc Biol; 2008 Oct; 28(10):1844-50. PubMed ID: 18617644
[TBL] [Abstract][Full Text] [Related]
18. Cellular localization of urokinase-type plasminogen activator, its inhibitors, and their mRNAs in breast cancer tissues.
Umeda T; Eguchi Y; Okino K; Kodama M; Hattori T
J Pathol; 1997 Dec; 183(4):388-97. PubMed ID: 9496254
[TBL] [Abstract][Full Text] [Related]
19. Fluvastatin inhibits basal and stimulated plasminogen activator inhibitor 1, but induces tissue type plasminogen activator in cultured human endothelial cells.
Mussoni L; Banfi C; Sironi L; Arpaia M; Tremoli E
Thromb Haemost; 2000 Jul; 84(1):59-64. PubMed ID: 10928471
[TBL] [Abstract][Full Text] [Related]
20. Identification of potentially effective antisense oligodeoxyribonucleotide (ODN) sequences for inhibiting plasminogen activator inhibitor-2 (PAI-2) production by monocytes.
Humphries J; Burnand KG; Cunningham P; Brock A; Westwood N; Smith A
Thromb Haemost; 2002 Jul; 88(1):131-6. PubMed ID: 12152653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
